Enanta Pharmaceuticals, Inc.
ENTA
$13.24
-$0.26-1.93%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -7.16% | -15.31% | -14.23% | -23.90% | -11.29% |
| Total Receivables | -21.81% | -80.73% | -78.85% | -82.19% | -79.43% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -25.99% | -23.11% | -59.36% | -30.80% | -32.90% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -8.57% | -26.54% | -25.90% | -31.85% | -22.29% |
|
|
|||||
| Total Current Assets | -8.57% | -26.54% | -25.90% | -31.85% | -22.29% |
| Net Property, Plant & Equipment | -9.45% | -9.29% | -7.44% | -0.55% | 12.99% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.46% | 1.33% | -0.03% | -0.06% | -0.32% |
| Total Assets | -1.38% | -2.57% | -5.49% | -25.47% | -24.52% |
|
|
|||||
| Total Accounts Payable | -7.16% | -8.26% | -60.11% | -75.66% | -66.77% |
| Total Accrued Expenses | -6.17% | -17.50% | -28.37% | -5.88% | -15.41% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 34.96% | 7.13% | 4.50% | -5.92% | -13.18% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 21.59% | 1.08% | -8.81% | -15.61% | -23.50% |
|
|
|||||
| Total Current Liabilities | 21.59% | 1.08% | -8.81% | -15.61% | -23.50% |
| Long-Term Debt | -26.13% | -22.18% | -20.56% | -17.40% | -15.36% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -7.02% | -6.65% | -4.73% | 1.51% | 15.62% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 13.49% | 14.40% | 14.47% | 12.55% | 11.01% |
| Total Liabilities | -11.70% | -13.66% | -14.32% | -12.84% | -11.27% |
|
|
|||||
| Common Stock & APIC | 18.36% | 18.53% | 18.95% | 4.08% | 4.99% |
| Retained Earnings | -16.37% | -16.84% | -20.72% | -25.35% | -31.27% |
| Treasury Stock & Other | -130.60% | -227.68% | -1,034.48% | -212.25% | 38.44% |
| Total Common Equity | 27.48% | 24.64% | 13.21% | -49.76% | -46.76% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 27.48% | 24.64% | 13.21% | -49.76% | -46.76% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 27.48% | 24.64% | 13.21% | -49.76% | -46.76% |
|
|
|||||